They supported the buyer by scouting the Italian market, identifying the most suitable target, and assisting in the LOI formulation and in negotiations throughout the process. Through the acquisition, Xbrane will be able to broaden their expertise within the field of high demand complex generics.
Read more about the transaction, market trends, deal drivers and M&A valuation aspects in the attached newsletter.
© 2019 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.